Standard BioTools (LAB) News Today $1.86 -0.09 (-4.38%) (As of 02:39 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Standard BioTools (NASDAQ:LAB) Shares Gap Up - Here's What HappenedDecember 1 at 1:53 AM | americanbankingnews.comShort Interest in Standard BioTools Inc. (NASDAQ:LAB) Decreases By 24.9%Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 14,680,000 shares, a decline of 24.9% from the October 31st total of 19,540,000 shares. Currently, 4.1% of the shares of the company are sold short. Based on an average trading volume of 1,860,000 shares, the short-interest ratio is currently 7.9 days.November 29, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Up - Time to Buy?Standard BioTools (NASDAQ:LAB) Shares Gap Up - Here's What HappenedNovember 29, 2024 | marketbeat.comSumitomo Mitsui Trust Group Inc. Has $18.49 Million Holdings in Standard BioTools Inc. (NASDAQ:LAB)Sumitomo Mitsui Trust Group Inc. decreased its stake in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 10.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,578,563 shares of the company's stock aNovember 18, 2024 | marketbeat.comARK Investment Management LLC Sells 3,729,626 Shares of Standard BioTools Inc. (NASDAQ:LAB)ARK Investment Management LLC lowered its stake in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 29.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,949,765 shares of the company's stock after selling 3November 8, 2024 | marketbeat.comStandard BioTools Appoints Alex Kim as Chief Financial OfficerNovember 7, 2024 | globenewswire.comStandard BioTools Inc.: Standard BioTools Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | finanznachrichten.deEarnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17November 4, 2024 | finance.yahoo.comStandard BioTools Inc. (LAB) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | seekingalpha.comStandard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ...October 31, 2024 | uk.finance.yahoo.comStandard BioTools: Resilient Sales Growth and Strategic Cost Management Drive Buy RatingOctober 31, 2024 | markets.businessinsider.comStandard BioTools Reports Strong Q3 2024 PerformanceOctober 31, 2024 | markets.businessinsider.comStandard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | msn.comStandard BioTools to Participate in Upcoming Investor ConferencesOctober 31, 2024 | globenewswire.comStandard BioTools Reports Third Quarter 2024 Financial ResultsOctober 30, 2024 | globenewswire.comStandard BioTools (NASDAQ:LAB) Trading 5.9% Higher - Should You Buy?Standard BioTools (NASDAQ:LAB) Trading 5.9% Higher - Here's What HappenedOctober 29, 2024 | marketbeat.comStandard BioTools (LAB) Scheduled to Post Quarterly Earnings on WednesdayStandard BioTools (NASDAQ:LAB) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=497828)October 23, 2024 | marketbeat.comMillennium Management LLC Acquires Shares in Standard BioTools IncOctober 22, 2024 | finance.yahoo.comStandard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024October 16, 2024 | globenewswire.comStandard BioTools (NASDAQ:LAB) Trading Down 4% - Here's WhyStandard BioTools (NASDAQ:LAB) Trading Down 4% - Should You Sell?October 14, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 904,474 Shares of Standard BioTools Inc. (NASDAQ:LAB)Dimensional Fund Advisors LP lessened its stake in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 71.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 362,385 shares of the company's stock after sellingOctober 14, 2024 | marketbeat.comMillennium Management LLC Sells 8,151,206 Shares of Standard BioTools Inc. (NASDAQ:LAB)Millennium Management LLC lowered its position in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 56.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,221,993 shares of the company's stock after selling 8,151,206 shares during theOctober 8, 2024 | marketbeat.comIs Standard BioTools Inc. (LAB) the Best NASDAQ Stock Under $5?October 3, 2024 | msn.comStandard BioTools Inc. (NASDAQ:LAB) Shares Bought by Rhumbline AdvisersRhumbline Advisers grew its holdings in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 3,691.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 407,467 shares of the company's stock after buying an additional 396,71September 25, 2024 | marketbeat.comMagnetar Financial LLC Reduces Stake in Standard BioTools Inc. (NASDAQ:LAB)Magnetar Financial LLC trimmed its position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 54.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 692,998 shares of the company's stock after sellSeptember 24, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading Down 4.5%Standard BioTools (NASDAQ:LAB) Stock Price Down 4.5%September 23, 2024 | marketbeat.comShareholders in Standard BioTools (NASDAQ:LAB) are in the red if they invested three years agoSeptember 19, 2024 | finance.yahoo.comBank of New York Mellon Corp Grows Stake in Standard BioTools Inc. (NASDAQ:LAB)Bank of New York Mellon Corp boosted its position in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 1,019.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 980,983 shares of the company's stock afterSeptember 19, 2024 | marketbeat.comStandard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)September 18, 2024 | markets.businessinsider.comStandard BioTools (NASDAQ:LAB) Shares Gap Down to $2.00Standard BioTools (NASDAQ:LAB) Shares Gap Down to $2.00September 18, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Down 2.4% Standard BioTools (NASDAQ:LAB) Stock Price Down 2.4%September 17, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Down to $1.94Standard BioTools (NASDAQ:LAB) Shares Gap Down to $1.94September 9, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Stock Price Down 4%Standard BioTools (NASDAQ:LAB) Stock Price Down 4%September 4, 2024 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Sees Significant Growth in Short InterestStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 21,800,000 shares, an increase of 12.3% from the July 31st total of 19,410,000 shares. Approximately 6.1% of the company's stock are sold short. Based on an average trading volume of 3,330,000 shares, the short-interest ratio is currently 6.5 days.September 1, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Up Following Insider Buying ActivityStandard BioTools (NASDAQ:LAB) Shares Gap Up on Insider Buying ActivityAugust 27, 2024 | marketbeat.comStandard BioTools And 3 Other Stocks Under $3 Executives Are BuyingAugust 27, 2024 | benzinga.comInsider Buying: Standard BioTools Inc. (NASDAQ:LAB) Director Purchases 150,000 Shares of StockAugust 27, 2024 | insidertrades.comStandard BioTools Inc. (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 150,000 SharesStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L bought 150,000 shares of the business's stock in a transaction that occurred on Monday, August 26th. The shares were bought at an average price of $2.15 per share, with a total value of $322,500.00. Following the transaction, the director now directly owns 53,775,821 shares in the company, valued at $115,618,015.15. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.August 26, 2024 | marketbeat.comAssenagon Asset Management S.A. Sells 160,522 Shares of Standard BioTools Inc. (NASDAQ:LAB)Assenagon Asset Management S.A. trimmed its position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 27.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 417,917 shares of the company's stAugust 24, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading Up 4.1% on Insider Buying ActivityStandard BioTools (NASDAQ:LAB) Shares Up 4.1% After Insider Buying ActivityAugust 22, 2024 | marketbeat.comCasdin Partners Master Fund, L Buys 250,000 Shares of Standard BioTools Inc. (NASDAQ:LAB) StockAugust 22, 2024 | insidertrades.comInsider Buying: Standard BioTools Inc. (NASDAQ:LAB) Director Buys 250,000 Shares of StockStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L bought 250,000 shares of the business's stock in a transaction that occurred on Monday, August 19th. The stock was purchased at an average price of $1.85 per share, for a total transaction of $462,500.00. Following the completion of the acquisition, the director now owns 52,025,821 shares in the company, valued at $96,247,768.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.August 21, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading Down 4.6%Standard BioTools (NASDAQ:LAB) Trading Down 4.6%August 21, 2024 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Shares Acquired by Sumitomo Mitsui Trust Holdings Inc.Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 20.2% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,642,271 shares of the company's stock after buying aAugust 21, 2024 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Director Casdin Partners Master Fund, L Acquires 1,200,000 SharesAugust 17, 2024 | insidertrades.comCasdin Partners Master Fund, L Acquires 1,200,000 Shares of Standard BioTools Inc. (NASDAQ:LAB) StockStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 1,200,000 shares of the business's stock in a transaction on Wednesday, August 14th. The stock was purchased at an average cost of $1.59 per share, for a total transaction of $1,908,000.00. Following the completion of the acquisition, the director now directly owns 51,775,821 shares of the company's stock, valued at approximately $82,323,555.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.August 16, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Up to $1.55Standard BioTools (NASDAQ:LAB) Shares Gap Up to $1.55August 15, 2024 | marketbeat.comStudy finds no clinically useful biomarkers for long COVID in routine lab testsAugust 14, 2024 | msn.comRoutine lab tests fail to identify reliable biomarkers for long COVID, study findsAugust 14, 2024 | msn.comStandard BioTools Inc. (NASDAQ:LAB) Director Acquires $820,000.00 in StockStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L acquired 500,000 shares of the business's stock in a transaction dated Monday, August 12th. The stock was acquired at an average price of $1.64 per share, for a total transaction of $820,000.00. Following the purchase, the director now directly owns 50,025,821 shares of the company's stock, valued at $82,042,346.44. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.August 13, 2024 | marketbeat.com Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address My most important prediction yet (Ad)One year ago at this time, I was gearing up to do something I’d never done before… After years of working behind the scenes, helping Tom Busby and teaching traders all about the markets, I was about ready to jump in front of a camera. Why? Because my research and years of expertise were showing me a phenomenon that people NEEDED to know about. That gold was setting up to go on a historic run that I called the “2024 Gold Supercycle.” I went LIVE on December 7, 2023, and made my bold prediction — staking 20+ years of a reputation on this one public prognostication. And the rest, as they say, is history… Gold went on to have its best year since 1979 — almost half a century! I’m going to tell you all about it on Wednesday, December 4th @ 1:00 PM ET, 362 days after I first made my prediction on gold. Go here and finish your registration to receive your access link LAB Media Mentions By Week LAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LAB News Sentiment▼1.100.87▲Average Medical News Sentiment LAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LAB Articles This Week▼53▲LAB Articles Average Week Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Transcat News Cytek Biosciences News EyePoint Pharmaceuticals News Quanterix News Aehr Test Systems News Nautilus Biotechnology News Senseonics News Quantum-Si News Seer News Frequency Electronics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LAB) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Standard BioTools Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Standard BioTools With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LAB Stock Alerts